Literature DB >> 3129610

Predominant synthesis of IgA with lambda light chain in IgA nephropathy.

K N Lai1, S H Chui, F M Lai, C W Lam.   

Abstract

The nature of the light chains in mesangial IgA deposits and serum IgA was studied in patients with IgA nephropathy. Immunofluorescence (IF) studies using murine monoclonal antibodies, rabbit and goat anti-human monospecific antisera were performed in kidney sections from 15 IgA nephritic patients with only IgA isotype detected in the renal biopsy. Lambda light chain IF was demonstrated in all biopsy specimens and kappa light chain IF in 11 renal biopsy specimens. The majority of renal biopsies showed a predominance of lambda light chain IF staining in the mesangial deposits. The concentration of individual immunoglobulins and their light chain fractions, and the kappa/lambda ratio were determined in the serum and the supernate from peripheral blood mononuclear cells culture of 30 IgA nephritic patients and 30 age-matched healthy controls. The IgA nephritic patients had a higher serum concentration of total IgA (P less than 0.001) and a significantly lower IgA kappa/lambda ratio (P less than 0.001) compared with the controls. The kappa/lambda ratio of supernatant IgA from IgA nephritic patients (N = 20) was also significantly lower than that of the normal subjects (N = 14), both in the unstimulated (P less than 0.01) and pokeweed mitogen stimulated, peripheral blood mononuclear-cell culture (P less than 0.05). Our results showed that patients with primary IgA nephropathy displayed a unique immunologic response characterized by a predominance of IgA with lambda light chain in circulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129610     DOI: 10.1038/ki.1988.37

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis.

Authors:  S Kodama; M Suzuki; M Arita; G Mogi
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.

Authors:  Hong Liu; Youming Peng; Fuyou Liu; Weiwei Xiao; Yu Zhang; Weiwei Li
Journal:  Inflamm Res       Date:  2011-05-26       Impact factor: 4.575

3.  Clinicopathological significance of light chain deposition in IgA nephropathy.

Authors:  Ritsuko Katafuchi; Hiroshi Nagae; Kosuke Masutani; Toshiaki Nakano; Mikio Munakata; Kazuhiko Tsuruya; Koji Mitsuiki
Journal:  Clin Exp Nephrol       Date:  2021-03-01       Impact factor: 2.801

4.  Effect of cyclosporine A on circulating immune complexes in IgA nephropathy.

Authors:  K N Lai; C W Lam; I K Cheng; J S Tam; F M Lai
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

5.  Light-chain ratio of serum IgA1 in IgA nephropathy.

Authors:  S H Chui; C W Lam; W H Lewis; K N Lai
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

6.  Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy.

Authors:  K N Lai; R T Ho; C K Lai; C H Chan; P K Li
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

7.  Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits.

Authors:  Ji Zhang; Ziyuan Huang; Sishi Lin; Ya Hu; Yan Liang; Wenxian Qiu; Bo Chen; Chaosheng Chen
Journal:  Kidney Int Rep       Date:  2022-01-26

8.  Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.

Authors:  Katerina Zachova; Jana Jemelkova; Petr Kosztyu; Yukako Ohyama; Kazuo Takahashi; Josef Zadrazil; Jiri Orsag; Karel Matousovic; Dana Galuszkova; Nadezda Petejova; Jiri Mestecky; Milan Raska
Journal:  J Am Soc Nephrol       Date:  2022-02-03       Impact factor: 14.978

Review 9.  Pathogenesis of Henoch-Schönlein purpura nephritis.

Authors:  Keith K Lau; Hitoshi Suzuki; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2009-06-13       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.